Evidence map›Paper›PMID 25429978›Full record

ArticleNucleic acids research2015

Identification of SMG6 cleavage sites and a preferred RNA cleavage motif by global analysis of endogenous NMD targets in human cells.

Skye A Schmidt, Patricia L Foley, Dong-Hoon Jeong, Linda A Rymarquis, Francis Doyle, Scott A Tenenbaum, Joel G Belasco, Pamela J Green

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. Nonsense-mediated mRNA decay: friend or foe in cancer biology?Cell communication and signaling : CCS · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Skye A SchmidtDelaware Biotechnology Institute and Department of Plant and Soil Sciences, University of Delaware, Newark, DE 19711, USA.
Patricia L FoleyKimmel Center for Biology and Medicine at the Skirball Institute and Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA.
Dong-Hoon JeongDelaware Biotechnology Institute and Department of Plant and Soil Sciences, University of Delaware, Newark, DE 19711, USA.
Linda A RymarquisDelaware Biotechnology Institute and Department of Plant and Soil Sciences, University of Delaware, Newark, DE 19711, USA.
Francis DoyleDepartment of Life Science, Hallym University, Chuncheon, Gangwon, Republic of Korea.
Scott A TenenbaumDepartment of Life Science, Hallym University, Chuncheon, Gangwon, Republic of Korea.
Joel G BelascoKimmel Center for Biology and Medicine at the Skirball Institute and Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA joel.belasco@med.nyu.edu.
Pamela J GreenDelaware Biotechnology Institute and Department of Plant and Soil Sciences, University of Delaware, Newark, DE 19711, USA green@dbi.udel.edu.
University of Delaware · USHallym University · KRNew York University · USBiotechnology Institute · US

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI Anjana Narayan Bhat · 2012 to 2026
$67.2M
INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
Prokaryotic RNA Metabolism - Resubmission - 1R01GM035769 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BELASCO, JOEL G · 1986 to 2021
$7.1M
Global Analysis of the Human RNA DegradomeR01GM096471 · NIGMS · UNIVERSITY OF DELAWARE · PI GREEN, PAMELA J. · 2010 to 2014
$2.3M
NIAID NIH HHS T32AI007180NIGMS NIH HHS P20 GM103446NIGMS NIH HHS R01 GM035769NIGMS NIH HHS R01 GM096471NIGMS NIH HHS R01GM096471
6 · The paper itself

Abstract

In metazoans, cleavage by the endoribonuclease SMG6 is often the first degradative event in non-sense-mediated mRNA decay (NMD). However, the exact sites of SMG6 cleavage have yet to be determined for any endogenous targets, and most evidence as to the identity of SMG6 substrates is indirect. Here, we use Parallel Analysis of RNA Ends to specifically identify the 5' termini of decay intermediates whose production is dependent on SMG6 and the universal NMD factor UPF1. In this manner, the SMG6 cleavage sites in hundreds of endogenous NMD targets in human cells have been mapped at high resolution. In addition, a preferred sequence motif spanning most SMG6 cleavage sites has been discovered and validated by mutational analysis. For many SMG6 substrates, depletion of SMG6 resulted in the accumulation of decapped transcripts, an effect indicative of competition between SMG6-dependent and SMG6-independent NMD pathways. These findings provide key insights into the mechanisms by which mRNAs targeted by NMD are degraded.

Indexed as

Nonsense Mediated mRNA DecayRNA CleavageEndoribonucleasesHeLa CellsHigh-Throughput Nucleotide SequencingHumansNucleotide MotifsRNA, MessengerSequence Analysis, RNATelomeraseEndoribonucleasesRNA, MessengerSMG6 protein, humanTelomerase

Identifiers

PMID25429978
PMCPMC4288159
OpenAlexW2031299035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.